Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Ametris (formerly ActiGraph), based on the scraped text, appears to be a digital health technology company serving the clinical research sector. It positions itself around driving the digital transformation of clinical research. Its core keyword is wearable digital health technology (DHT) solutions. Since the page content is extremely brief, we can only confirm that it focuses on clinical research and wearable health data. It is not possible to determine whether its specific product form is hardware, a SaaS platform, a data analytics system, or an end-to-end research service.
In terms of core functional modules, the text only mentions “wearable DHT solutions.” This suggests a connection with wearable data collection or digitized research workflows in clinical studies, but it does not disclose specific capabilities such as device management, participant data collection, remote monitoring, data analytics, report generation, or study project management. For enterprise software buyers, the currently available scraped information is not sufficient for a module-level evaluation.
Third-party integrations, team collaboration and permissions, APIs, and developer support are not mentioned in the body text. For clinical research SaaS products, these capabilities are usually critical—for example, integrations with EDC, ePRO, CTMS, or data warehouses—but the text provides no evidence to support a positive assessment.
The scraped content does not provide plans, pricing methods, free versions, or trial information. It also does not state whether billing is based on devices, research projects, participant count, or enterprise contracts. The deployment model is also unknown, so it is not possible to confirm whether it is cloud-based, self-hosted, or hybrid. Data security and compliance are not disclosed either; common clinical research compliance requirements such as HIPAA, GDPR, and 21 CFR Part 11 do not appear in the text.
The main advantage is its clear positioning: it focuses on clinical research digitization and the specialized area of wearable DHT. It may be worth initial attention from research organizations evaluating digital endpoints, remote data collection, or wearable health data solutions. The downside is that public information is too limited, lacking the functional, pricing, compliance, integration, and service support details that enterprise buyers care about most.
Access from China is unknown, and the text does not provide information on payment methods or localization support. If a China-based team plans to use it, they should prioritize confirming website accessibility, contracting and payment options, cross-border data transfer and compliance requirements, and whether local service support is available. Alternatives should be selected based on specific needs; the current text is insufficient to list directly comparable products.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on ametris.com official site.
ametris.com is an United States Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach ametris.com directly.